DSM and Firmenich’s mooted 2023 ‘Merger of Equals’ will create a nutrition, food ingredients and fragrances behemoth with 277 years of collective business experience and a combined annual revenue pushing towards €12 billion (£10.2bn).
The deal rivals that of the 2021 €20bn+ (£17bn+) merger between International Flavors & Fragrances (IFF) and DuPont’s Nutrition and Biosciences division.
The Dutch and Swiss firms have spoken much of the synergies they predict will save at least €175 million (£149m), while not cutting too many of 28,000 jobs and keeping annual R&D spends higher than most rivals at 9.3% of revenue – about €700m (£145m).
By comparison, Givaudan spends 8.4% of its revenues on R&D, IFF/DuPont 6.1% and Symrise 5.9%.
As the nutrition science consensus shifts in favor of saturated fat after decades in the dietary sin bin over odious health links, dairy players say it’s time for full-fat segregation to end – especially as dairy under-consumption remains prevalent across the globe.
Armed with what they consider compelling dairy consumption statistics plus an ever-growing body of peer-reviewed research showing saturated fat is probably not – at least singularly – the agent of ailments like high cholesterol, heart disease and obesity it has been tagged with down the decades, the push to have full-fat dairy reinstated in national dietary guidelines is well and truly on.
‘Satfat’-friendly data is being presented to the committees that inform such guidelines while multi-channel dairy education campaigns aimed at consumers, regulators and the broader food industry are amplifying the full-fat dairy message and its potential to elevate across-the-board dairy consumption.